Please check the following:
- {{x.value}}
FREE membership
FREE membership
Join Intelligent Investor today
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
Please enter the 5 digit verification code sent to "{{user.DayPhone}}" Change number
We cannot send you a verification code via SMS to "{{user.DayPhone}}" Change number
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
Thank you
We have sent you an email with the details of your registration.
Purchase order
Sign up
Log in
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Log in
Upgrade Today
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
{{eventFunction.Name}}
{{eventFunction.EventTypeName}}
{{eventFunction.StartDate}}
{{eventFunction.EventTimings}}
{{eventFunction.VenueName}}
{{ t.Cost === 0 ? "FREE" : "$" + t.Cost.toFixed(2) }}
Quantity *
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
Congratulations!
You now have free access to InvestSMART, we look forward to helping you on your financial journey.
You now have access to Free Eureka Report Insights, We look forward to helping you on your financial journey.
You now have access to Intelligent Investor Free Insights. We look forward to helping you build a market beating stock portfolio.
Looking for more…
Intelligent Investor Membership
15-day Free Trial
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
No thanks
Looking for more…
Eureka Report Membership
15-day Free Trial
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
No thanks
Resonance Health Limited (ASX: RHT) - Share Price and Research
- Current share price for RHT : $0.085
Resonance Health Limited (RHT), an ASX-listed company, is an Australian healthcare technology and services company, specialising in the development and delivery of noninvasive medical imaging software and services. The Companys products are used globally by clinicians in the diagnosis and management of human diseases and by pharmaceutical and therapeutic companies in their clinical trials.
RHT General Information +
| ASX Code | RHT |
| Website | http://www.resonancehealth.com |
| Industry/Sector | Health Care Equipment |
| Market Cap ($M) | 37 |
| RHT Share Price | $0.085 |
| Day High | $0.085 |
| Day Low | $0.080 |
| Last Close | $0.085 |
| RHT Share Price Movement | - ( No change ) |
Prices as at 16:40, 18 Apr 2024
+Security prices are delayed by at least 20 minutes and are indicative only.
RHT Related Research
Resonance Health Limited (RHT) Upcoming Dividends & Yields
There are no dividends for Resonance Health Limited (RHT). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Resonance Health Limited (RHT) Recent ASX Announcements
| Headline | Annoucement date/time+ | Price at announcement+ | Current price+ | Price 7D Avg | Gain/Loss |
|---|---|---|---|---|---|
| Change of Director's Interest Notice - Simon Panton | 9 Apr 2024 7:08PM | $0.074 | $0.085 | $0.075 | risen by 14.86% |
| Investor Presentation - TrialsWest Acquisition | 2 Apr 2024 2:32PM | $0.070 | $0.085 | $0.075 | risen by 21.43% |
| Acquisition of TrialsWest Group | 2 Apr 2024 2:31PM | $0.070 | $0.085 | $0.075 | risen by 21.43% |
- + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.
See all ASX announcements from Resonance Health Limited (RHT) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.
RHT Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2023A | -$0.75 | -$0.20 | -36.00% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2022A | -$1.14 | -$0.30 | -292.30% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2021A | $0.59 | $0.10 | -176.50% | 135.20 | 0.00 | 0.00% | 0.0% |
RHT Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2021 A | 2022 A | 2023 A | 2021 A | 2022 A | 2023 A | 2021 A | 2022 A | 2023 A | ||
| Cochlear (COH) | $20,843M | 0.1063 | 0.3407 | 0.1157 | 68.7225 | 51.2596 | 45.9426 | 1.04% | 1.32% | 1.52% |
| Fisher & Paykel Hlth (FPH) | $14,366M | -0.3337 | 0.0134 | 0.3118 | 61.1180 | 60.3089 | 45.9727 | 1.66% | 1.33% | 1.47% |
| Resonance Health (RHT) | $38M | -0.3600 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| ResMed (RMD) | $17,929M | 0.1879 | 0.0960 | 0.1089 | 31.3130 | 28.5714 | 25.7650 | 0.71% | 0.95% | 1.05% |
RHT Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 3.95 | 0.00 |
| Market | 0.53 | 15.30 | 1.11 | 1.01 |
| Sector | 0.84 | 33.30 | 2.35 | 2.42 |
RHT Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Mitchell MacDonald Wells | Company Secretary, Non Executive Director | 28 Feb 2018 |
| Mr Simon Panton | Non-Executive Director | 5 Oct 2009 |
| Dr Travis Baroni | Non-Executive Director | 25 Nov 2016 |
| Mr Aaron Brinkworth | Non-Executive Director | 27 Mar 2023 |
| Mr Martin Peter Blake | Non-Executive Director, Non-Executive Chairman | 3 Oct 2007 |
Resonance Health Limited (RHT) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 8 Apr 2024 | PANTON, Simon | Buy | Indirect Shares | 500,000 | $0.065 | $32,500.000 |
| 20 Mar 2024 | PANTON, Simon | Buy | Indirect Shares | 500,000 | $0.046 | $23,000.000 |
| 20 Oct 2023 | WELLS, Mitchell | Exercise | Related Securities | 610,000 | $0.060 | $36,600.000 |
See all changes in directors' interest & trades for Resonance Health Limited (RHT) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
RHT Management
| Name | Position |
|---|---|
| Andrew Duncan Harrison | Chief Executive Officer |
| Ms Liesl Ellies | Joint Company secretary |
RHT Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Resonance Health Limited (RHT). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 73,800,000 (16%) | Southam Investments 2003 P/L (Warwickshire Investments A/C) |
| 48,501,078 (10.52%) | HSBC Custody Nominees (Australia) Limited |
RHT Calendar of Events
| Date | Event |
|---|---|
| 26 February 2025 | Report (Interim) |
| 28 August 2024 | Report (Annual) |
| 28 August 2024 | Report (Prelim) |
FAQs about Resonance Health Limited (RHT)
What is the current share price of Resonance Health Limited (RHT)?
Resonance Health Limited's (RHT) current share price is $0.09. This constitutes a price movement of 13.33% when compared to the share price 7 days ago and is 0% below RHT's 12-month high of $0.09 per share. Prices are delayed by at least 20 minutes.
What is the share price movement for Resonance Health Limited (RHT)?
Relative to the previous close share price of $0.09, Resonance Health Limited's (RHT) current share price of $0.09 constitutes a movement of or 0%. Resonance Health Limited's (RHT) share price movement is 13.33% when compared to 7 days ago and is 0% below RHT's 52-week high of $0.09.
What is the 52-week high share price for Resonance Health Limited (RHT)?
Resonance Health Limited's (RHT) 52-week high is $0.09 which was reached on 18 Apr 2024. Relative to this, RHT's current share price of $0.09 constitutes a or 0% drop since that high of $0.09 per RHT share.
What is the 52-week low share price for Resonance Health Limited (RHT)?
Resonance Health Limited's (RHT) 52-week low is $0.04 which was reached on 14 Jun 2023. Relative to this, RHT's current share price of $0.09 constitutes a $0.05 or 129.73% gain since that low of $0.04 per RHT share.
What is the daily average trading volume for Resonance Health Limited (RHT)?
Over the last 12 months, Resonance Health Limited (RHT) has a daily average trading volume of 165,498 RHT shares per day.
What is the dividend yield for Resonance Health Limited (RHT)?
Resonance Health Limited (RHT) has a current dividend yield of n/a this year. Last year's dividend yield was 0%. The dividend yield for RHT is a ratio that tells you the percentage of Resonance Health Limited's (RHT) share price that it pays out in dividends each year.
When does Resonance Health Limited (RHT) release its next Annual Report?
Resonance Health Limited (RHT) will release its next Annual Report on 28 August 2024. Resonance Health Limited's (RHT) last annual report was released on 30 Aug 2023. Click here to view Resonance Health Limited's (RHT) last annual report.
In which sector is Resonance Health Limited (RHT) classified?
Resonance Health Limited (RHT) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), Cochlear Limited (COH), ResMed Inc. (RMD), and Fisher & Paykel Healthcare Corporation Limited (FPH).
What is the price-to-earnings (P/E) ratio for Resonance Health Limited (RHT)?
The price-to-earnings (P/E) ratio for Resonance Health Limited (RHT) is 0. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of Resonance Health Limited's (RHT) share price to its earnings per RHT share.
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
